table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
heterologous prime-boost CombiVacS

2 studies excluded by filtering options 1

7069 Hillus, 2021 0100selection pending
8145 Normark, 2021 0100selection pending

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons